These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10861611)

  • 21. Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas.
    Carvalho PE; Antonãngelo L; Bernardi FD; Leão LE; Rodrigues OR; Capelozzi VL
    Jpn J Clin Oncol; 2000 Nov; 30(11):478-86. PubMed ID: 11155917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
    Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
    Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
    Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
    Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL
    Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.
    Ludovini V; Bellezza G; Pistola L; Bianconi F; Di Carlo L; Sidoni A; Semeraro A; Del Sordo R; Tofanetti FR; Mameli MG; Daddi G; Cavaliere A; Tonato M; Crinò L
    Ann Oncol; 2009 May; 20(5):842-9. PubMed ID: 19153117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of prognostic predictors for non-small cell lung cancer.
    Fu XL; Zhu XZ; Shi DR; Xiu LZ; Wang LJ; Zhao S; Qian H; Lu HF; Xiang YB; Jiang GL
    Lung Cancer; 1999 Feb; 23(2):143-52. PubMed ID: 10217618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer.
    Kwa HB; Michalides RJ; Dijkman JH; Mooi WJ
    Lung Cancer; 1996 Jun; 14(2-3):207-17. PubMed ID: 8794404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 labeling index is associated with recurrence after segmentectomy under video-assisted thoracoscopic surgery in stage I non-small cell lung cancer.
    Yamashita S; Moroga T; Tokuishi K; Miyawaki M; Chujo M; Yamamoto S; Kawahara K
    Ann Thorac Cardiovasc Surg; 2011; 17(4):341-6. PubMed ID: 21881319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
    Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of biological parameters on fine-needle aspirates from non-small cell lung cancer.
    Bozzetti C; Guazzi A; Nizzoli R; Naldi N; Franciosi V; Cascinu S
    Methods Mol Med; 2003; 75():405-20. PubMed ID: 12407756
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
    Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
    Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis bcl-2 and p53 expression and their relation to tumour stage in non-small cell lung carcinomas (NSCLC).
    Kargi HA; Aktaş S; Sagol O; Ermete S; Akpinar O; Akkoçlu A
    Cancer Lett; 1997 Jun; 116(2):185-9. PubMed ID: 9215862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 and bcl-2 protein expression in non-small-cell lung carcinoma.
    Athanassiadou P; Dosios T; Petrakakou E; Liossi A; Zerva C; Athanassiades P
    Diagn Cytopathol; 1998 Oct; 19(4):255-9. PubMed ID: 9784987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
    Yaman B; Nart D; Ekren PK; Çok G; Veral A
    Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Nakamori S; Tateishi R
    J Surg Oncol; 1997 Jan; 64(1):48-54. PubMed ID: 9040801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.